3-(5-Amino-4-cyano-3-methyl-pyrazol-1-yl)-benzoic acid ethyl ester, 95.0%, 1g

2-CHLORO-7-(PHENYLSULFONYL)-7H-PYRROLO[2,3-D]PYRIMIDINE, 95.0%, 1g

(4-(Cyclohexyl(methyl)carbamoyl)phenyl)boronic acid, 95.0%, 250mg

2,4-Pyrimidinediamine, 5-chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-, hydrochloride (1:2), 50mg

5-Amino-1-ethyl-1H-pyrazole-4-carbonitrile, 97%, 1g

trans-1,2-Dibenzoylethylene, 98.0%, 5g

N-(2-(DIMETHYLAMINO)CYCLOPENTYL)-4-METHYLBENZENESULFONAMIDE, 95.0%, 250mg

Magnesium nitrate matrix modifier solution, 20 g/L Mg(NO3)2 (99.999%) in H2O, 50 mL

(2-Methylpyrimidin-5-yl)methanamine, 95.0%, 500mg

tert-Butyl-2,2,2-trichloroacetimidate, 97.0%, 100g

Methyl 5-amino-1-methyl-1H-pyrazole-3-carboxylate, 95.0%, 250mg

tert-Butyl N-[(2S,3R)-2-methylazetidin-3-yl]carbamate hydrochloride, 98%, 100mg

(R)-2-((tert-Butoxycarbonyl)amino)oct-7-enoic acid, 95%, 250mg